These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28521762)

  • 1. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study.
    Vikelis M; Dermitzakis EV; Spingos KC; Vasiliadis GG; Vlachos GS; Kararizou E
    BMC Neurol; 2017 May; 17(1):97. PubMed ID: 28521762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.
    Di Fiore P; Bussone G; Galli A; Didier H; Peccarisi C; D'Amico D; Frediani F
    Neurol Sci; 2017 May; 38(Suppl 1):201-206. PubMed ID: 28527053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly
    Przeklasa-Muszyńska A; Skrzypiec K; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J
    Neurol Neurochir Pol; 2017; 51(2):127-134. PubMed ID: 28159327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients.
    Danno D; Iigaya M; Imai N; Igarashi H; Takeshima T
    Sci Rep; 2019 Jul; 9(1):9900. PubMed ID: 31289281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly
    Riederer F; Penning S; Schoenen J
    Pain Ther; 2015 Oct; 4(2):135-47. PubMed ID: 26467451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population.
    Magis D; Sava S; d'Elia TS; Baschi R; Schoenen J
    J Headache Pain; 2013 Dec; 14(1):95. PubMed ID: 24289825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurostimulation of the supraorbital nerve with the Cefaly device - a new method for the treatment of migraine].
    Tabeeva GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):133-140. PubMed ID: 31089108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine Prevention Using Different Frequencies of Transcutaneous Occipital Nerve Stimulation: A Randomized Controlled Trial.
    Liu Y; Dong Z; Wang R; Ao R; Han X; Tang W; Yu S
    J Pain; 2017 Aug; 18(8):1006-1015. PubMed ID: 28428093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromyography data in chronic migraine patients by using neurostimulation with the Cefaly® device.
    Didier HA; Di Fiore P; Marchetti C; Tullo V; Frediani F; Arlotti M; Giannì AB; Bussone G
    Neurol Sci; 2015 May; 36 Suppl 1():115-9. PubMed ID: 26017525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Update of Chronic Migraine.
    Cho SJ; Song TJ; Chu MK
    Curr Pain Headache Rep; 2017 Jun; 21(6):26. PubMed ID: 28424953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External trigeminal neurostimulation in patients with chronic migraine.
    Trimboli M; Marsico O; Troisi L; Fasano F
    Pain Manag; 2023 Mar; 13(3):185-192. PubMed ID: 37010047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.